Advanced case of PKDL due to delayed treatment: A rare case report.
Clicks: 106
ID: 101052
2020
Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral leishmaniasis (VL) and is thought to be the potential reservoir of parasite. Miltefosine (MF) is the only oral drug existing for treatment of post-kala-azar dermal leishmaniasis (PKDL). Increased miltefosine tolerance in clinical isolates of Leishmania donovani has been reported and is one of the major concerns in the treatment of PKDL. Here, we report a highly ulcerated PKDL case that was successfully cured after miltefosine treatment.
| Reference Key |
topno2020advancedplos
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Topno, Roshan Kamal;Rabi Das, Vidya Nand;Kumar, Maneesh;Madhukar, Major;Pandey, Krishna;Verma, Neena;Agrawal, Kanhaiya;Lal, Chandra Shekhar;Siddiqui, Niyamat Ali;Bimal, Sanjiva;Das, Pradeep; |
| Journal | plos neglected tropical diseases |
| Year | 2020 |
| DOI | 10.1371/journal.pntd.0008052 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.